Science Applications International Corp
F:85S
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (3.4), the stock would be worth €95.35 (20% upside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 2.8 | €79.3 |
0%
|
| 3-Year Average | 3.4 | €95.35 |
+20%
|
| 5-Year Average | 3.2 | €90.41 |
+14%
|
| Industry Average | 3.5 | €100.12 |
+26%
|
| Country Average | 2.5 | €71.08 |
-10%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Science Applications International Corp
F:85S
|
4.2B EUR | 2.8 | 11.8 | |
| UK |
|
Relx PLC
LSE:REL
|
49B GBP | 20.7 | 23.7 | |
| UK |
I
|
IHS Markit Ltd
F:0M3
|
37.9B EUR | 4.6 | 36.5 | |
| CA |
|
Thomson Reuters Corp
TSX:TRI
|
55B CAD | 3.3 | 26.1 | |
| IE |
|
Experian PLC
LSE:EXPN
|
25.1B GBP | 6.2 | 24.6 | |
| US |
|
Verisk Analytics Inc
NASDAQ:VRSK
|
24.6B USD | 79.7 | 27.1 | |
| CH |
|
SGS SA
SIX:SGSN
|
16.5B CHF | 18.3 | 24.7 | |
| US |
|
Equifax Inc
NYSE:EFX
|
20.6B USD | 4.5 | 29.4 | |
| US |
|
Leidos Holdings Inc
NYSE:LDOS
|
18.5B USD | 3.8 | 12.7 | |
| US |
U
|
UL Solutions Inc
NYSE:ULS
|
18.1B USD | 0 | 0 | |
| NL |
|
Wolters Kluwer NV
AEX:WKL
|
15B EUR | 18.8 | 11.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.5 |
| Median | 2.5 |
| 70th Percentile | 4.8 |
| Max | 147 580.5 |
Other Multiples
Science Applications International Corp
Glance View
Science Applications International Corporation, better known as SAIC, traces its origins back to 1969 when it was founded by Dr. J. Robert Beyster. Situated at the intersection of science, engineering, and technology, the company crafts a compelling narrative of innovation and service. SAIC carved a niche by merging theoretical science with practical solutions, which allowed it to become a formidable contractor primarily for the United States government. It builds its reputation on expertise in IT modernization, cloud migration, and cybersecurity. Over the years, SAIC's ability to stay at the cutting edge of technology while maintaining a strong service-oriented ethos has firmly anchored it in defense, space, and intelligence sectors. SAIC's business model thrives on long-term contracts and a robust portfolio of solutions that support national security, civilian, and health markets. The company distinguishes itself by addressing client needs through tailored IT services, integrating systems engineering, and managing critical infrastructure. Its revenue streams primarily flow from complex projects where it offers end-to-end solutions, generating income not just from providing immediate technology fixes but through lifecycle service contracts. The firm's strategic push into digital transformation aligns with broader governmental goals of increasing efficiency and data security, ensuring SAIC remains a key player in governmental contracting circles.